Cancer associated serum antigen (CASA) levels in patients with breast carcinoma and in 3 control groups without breast cancer.
We have examined the predictive value of measurements of CASA (Cancer Associated Serum Antigen) levels in patients with breast carcinoma. The measurement uses monoclonal antibodies that bind to an epitope on the polymorphic epithelial mucin. CASA levels were of less value compared with the levels of other tumor markers (CA 15-3, CA 549 and CEA) in the management of patients with early breast cancer.
Meisel
M
M
Department of Gynecology and Obstetrics, Ernst-Moritz-Arndt-University, Greifswald, Germany.
Weise
J
J
Schwesinger
G
G
Straube
W
W
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D005348:Fibrocystic Breast Disease / Q000097:blood / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D018396:Mucin-1 / Q000097:blood*; D009367:Neoplasm Staging; D011379:Prognosis; D012016:Reference Values
D014408:Biomarkers, Tumor; D018396:Mucin-1